Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Goldman

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
The Lancet. Infectious Diseases|July 17, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled studyOnyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, et al.
Cell Reports|October 4, 2023
Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2Alphonsus H C Ng, Huiqian Hu, Kai Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical TrialMeghan E Sise, Jose Ramon Santos, Jason D Goldman, et al.
Nature Biotechnology|September 7, 2021
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19Jihoon W Lee, Yapeng Su, Priyanka Baloni, et al.
Plos One|June 4, 2025
Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohortsShannon Wuller, Nora G Singer, Colby Lewis, et al.
Plos One|November 17, 2021
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infectionYonghou Jiang, Fergal Duffy, Jennifer Hadlock, et al.
Communications Biology|May 16, 2023
Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysisWilliam Chour, Jongchan Choi, Jingyi Xie, et al.
Research Square|August 15, 2020
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2Sean Nolan, Marissa Vignali, Mark Klinger, et al.
The New England Journal of Medicine|May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Jason D Goldman, David C B Lye, David S Hui, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
The Lancet. Infectious Diseases|July 17, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled studyOnyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, et al.
Cell Reports|October 4, 2023
Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2Alphonsus H C Ng, Huiqian Hu, Kai Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical TrialMeghan E Sise, Jose Ramon Santos, Jason D Goldman, et al.
Nature Biotechnology|September 7, 2021
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19Jihoon W Lee, Yapeng Su, Priyanka Baloni, et al.
Plos One|June 4, 2025
Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohortsShannon Wuller, Nora G Singer, Colby Lewis, et al.
Plos One|November 17, 2021
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infectionYonghou Jiang, Fergal Duffy, Jennifer Hadlock, et al.
Communications Biology|May 16, 2023
Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysisWilliam Chour, Jongchan Choi, Jingyi Xie, et al.
Research Square|August 15, 2020
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2Sean Nolan, Marissa Vignali, Mark Klinger, et al.
The New England Journal of Medicine|May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Jason D Goldman, David C B Lye, David S Hui, et al.
Pageof 7